Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Vij

Showing results (261-270 of 283) with videos related to

Pageof 29
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2016
Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic SyndromeBrian C Shaffer, Kwang Woo Ahn, Zhen-Huan Hu, et al.
Bone Marrow Transplantation|February 1, 2018
Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantationLucie M Turcotte, Tao Wang, Michael T Hemmer, et al.
Haematologica|March 18, 2017
Improved survival after acute graft-<i>versus</i>-host disease diagnosis in the modern eraHanna J Khoury, Tao Wang, Michael T Hemmer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 29, 2018
Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic TransplantationSaurabh Chhabra, Ying Liu, Michael T Hemmer, et al.
American Journal of Hematology|March 10, 2016
Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practiceArtur Jurczyszyn, Norbert Grzasko, Alessandro Gozzetti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 20, 2016
Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple MyelomaRobert F Cornell, Anita D'Souza, Adetola A Kassim, et al.
Nature|November 2, 2023
Epigenetic regulation during cancer transitions across 11 tumour typesNadezhda V Terekhanova, Alla Karpova, Wen-Wei Liang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 20, 2014
Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survivalBrian L McClune, Kwang Woo Ahn, Hai-Lin Wang, et al.
JAMA Oncology|January 13, 2022
Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated DonorsGuru Subramanian Guru Murthy, Soyoung Kim, Zhen-Huan Hu, et al.
Nature|March 25, 2011
Initial genome sequencing and analysis of multiple myelomaMichael A Chapman, Michael S Lawrence, Jonathan J Keats, et al.
Pageof 29

Showing results (261-270 of 283) with videos related to

Sort By:
Pageof 29
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2016
Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic SyndromeBrian C Shaffer, Kwang Woo Ahn, Zhen-Huan Hu, et al.
Bone Marrow Transplantation|February 1, 2018
Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantationLucie M Turcotte, Tao Wang, Michael T Hemmer, et al.
Haematologica|March 18, 2017
Improved survival after acute graft-<i>versus</i>-host disease diagnosis in the modern eraHanna J Khoury, Tao Wang, Michael T Hemmer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 29, 2018
Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic TransplantationSaurabh Chhabra, Ying Liu, Michael T Hemmer, et al.
American Journal of Hematology|March 10, 2016
Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practiceArtur Jurczyszyn, Norbert Grzasko, Alessandro Gozzetti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 20, 2016
Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple MyelomaRobert F Cornell, Anita D'Souza, Adetola A Kassim, et al.
Nature|November 2, 2023
Epigenetic regulation during cancer transitions across 11 tumour typesNadezhda V Terekhanova, Alla Karpova, Wen-Wei Liang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 20, 2014
Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survivalBrian L McClune, Kwang Woo Ahn, Hai-Lin Wang, et al.
JAMA Oncology|January 13, 2022
Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated DonorsGuru Subramanian Guru Murthy, Soyoung Kim, Zhen-Huan Hu, et al.
Nature|March 25, 2011
Initial genome sequencing and analysis of multiple myelomaMichael A Chapman, Michael S Lawrence, Jonathan J Keats, et al.
Pageof 29